Amal Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 8, 2025, 10:58 pm

Competitors of Amal Ltd

All Competitor Stocks of Amal Ltd

Quarterly Result

Last Updated: July 16, 2025, 2:57 pm

Below is a detailed analysis of the quarterly data for Amal Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 47.31 Cr.. The value appears strong and on an upward trend. It has increased from 38.96 Cr. (Mar 2025) to 47.31 Cr., marking an increase of 8.35 Cr..
• For Expenses, as of Jun 2025, the value is 35.68 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.48 Cr. (Mar 2025) to 35.68 Cr., marking an increase of 7.20 Cr..
• For Operating Profit, as of Jun 2025, the value is 11.63 Cr.. The value appears strong and on an upward trend. It has increased from 10.48 Cr. (Mar 2025) to 11.63 Cr., marking an increase of 1.15 Cr..
• For OPM %, as of Jun 2025, the value is 24.58%. The value appears to be declining and may need further review. It has decreased from 26.90% (Mar 2025) to 24.58%, marking a decrease of 2.32%.
• For Other Income, as of Jun 2025, the value is 0.44 Cr.. The value appears strong and on an upward trend. It has increased from 0.28 Cr. (Mar 2025) to 0.44 Cr., marking an increase of 0.16 Cr..
• For Interest, as of Jun 2025, the value is 0.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.17 Cr. (Mar 2025) to 0.14 Cr., marking a decrease of 0.03 Cr..
• For Depreciation, as of Jun 2025, the value is 2.34 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.32 Cr. (Mar 2025) to 2.34 Cr., marking an increase of 0.02 Cr..
• For Profit before tax, as of Jun 2025, the value is 9.59 Cr.. The value appears strong and on an upward trend. It has increased from 8.27 Cr. (Mar 2025) to 9.59 Cr., marking an increase of 1.32 Cr..
• For Tax %, as of Jun 2025, the value is 1.98%. The value appears to be improving (decreasing) as expected. It has decreased from 18.14% (Mar 2025) to 1.98%, marking a decrease of 16.16%.
• For Net Profit, as of Jun 2025, the value is 9.40 Cr.. The value appears strong and on an upward trend. It has increased from 6.78 Cr. (Mar 2025) to 9.40 Cr., marking an increase of 2.62 Cr..
• For EPS in Rs, as of Jun 2025, the value is 7.60. The value appears strong and on an upward trend. It has increased from 5.48 (Mar 2025) to 7.60, marking an increase of 2.12.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:36 pm

Growth

Last Updated: September 5, 2025, 2:11 pm

Balance Sheet

Last Updated: July 25, 2025, 1:55 pm

Below is a detailed analysis of the balance sheet data for Amal Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 87.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Mar 2024) to 87.00 Cr., marking an increase of 29.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 24.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 24.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 22.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.00 Cr. (Mar 2024) to 22.00 Cr., marking an increase of 9.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 122.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 106.00 Cr. (Mar 2024) to 122.00 Cr., marking an increase of 16.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 80.00 Cr.. The value appears to be declining and may need further review. It has decreased from 86.00 Cr. (Mar 2024) to 80.00 Cr., marking a decrease of 6.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 20.00 Cr., marking an increase of 19.00 Cr..
• For Other Assets, as of Mar 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2024) to 21.00 Cr., marking an increase of 2.00 Cr..
• For Total Assets, as of Mar 2025, the value is 122.00 Cr.. The value appears strong and on an upward trend. It has increased from 106.00 Cr. (Mar 2024) to 122.00 Cr., marking an increase of 16.00 Cr..

Notably, the Reserves (87.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Amal Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 23.69. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 23.69, marking an increase of 22.46.
• For Diluted EPS (Rs.), as of Mar 25, the value is 23.69. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 23.69, marking an increase of 22.46.
• For Cash EPS (Rs.), as of Mar 25, the value is 31.13. This value is within the healthy range. It has increased from 8.69 (Mar 24) to 31.13, marking an increase of 22.44.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 80.22. It has increased from 56.53 (Mar 24) to 80.22, marking an increase of 23.69.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 80.22. It has increased from 56.53 (Mar 24) to 80.22, marking an increase of 23.69.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 109.46. It has increased from 69.64 (Mar 24) to 109.46, marking an increase of 39.82.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 35.46. This value is within the healthy range. It has increased from 12.57 (Mar 24) to 35.46, marking an increase of 22.89.
• For PBIT / Share (Rs.), as of Mar 25, the value is 28.02. This value is within the healthy range. It has increased from 5.26 (Mar 24) to 28.02, marking an increase of 22.76.
• For PBT / Share (Rs.), as of Mar 25, the value is 26.38. This value is within the healthy range. It has increased from 2.25 (Mar 24) to 26.38, marking an increase of 24.13.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 23.69. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 23.69, marking an increase of 22.31.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.69. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 23.69, marking an increase of 22.31.
• For PBDIT Margin (%), as of Mar 25, the value is 32.39. This value is within the healthy range. It has increased from 18.04 (Mar 24) to 32.39, marking an increase of 14.35.
• For PBIT Margin (%), as of Mar 25, the value is 25.59. This value exceeds the healthy maximum of 20. It has increased from 7.55 (Mar 24) to 25.59, marking an increase of 18.04.
• For PBT Margin (%), as of Mar 25, the value is 24.10. This value is within the healthy range. It has increased from 3.22 (Mar 24) to 24.10, marking an increase of 20.88.
• For Net Profit Margin (%), as of Mar 25, the value is 21.64. This value exceeds the healthy maximum of 10. It has increased from 1.97 (Mar 24) to 21.64, marking an increase of 19.67.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 21.64. This value exceeds the healthy maximum of 20. It has increased from 1.97 (Mar 24) to 21.64, marking an increase of 19.67.
• For Return on Networth / Equity (%), as of Mar 25, the value is 29.53. This value is within the healthy range. It has increased from 2.43 (Mar 24) to 29.53, marking an increase of 27.10.
• For Return on Capital Employeed (%), as of Mar 25, the value is 34.40. This value is within the healthy range. It has increased from 7.29 (Mar 24) to 34.40, marking an increase of 27.11.
• For Return On Assets (%), as of Mar 25, the value is 24.08. This value is within the healthy range. It has increased from 1.60 (Mar 24) to 24.08, marking an increase of 22.48.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.26 (Mar 24) to 0.00, marking a decrease of 0.26.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.33 (Mar 24) to 0.00, marking a decrease of 0.33.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.19. It has increased from 0.76 (Mar 24) to 1.19, marking an increase of 0.43.
• For Current Ratio (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has increased from 0.99 (Mar 24) to 1.89, marking an increase of 0.90.
• For Quick Ratio (X), as of Mar 25, the value is 1.61. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.61, marking an increase of 0.82.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.91. This value exceeds the healthy maximum of 8. It has decreased from 15.37 (Mar 24) to 13.91, marking a decrease of 1.46.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 21.62. This value is within the healthy range. It has increased from 4.17 (Mar 24) to 21.62, marking an increase of 17.45.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 15.44. This value is within the healthy range. It has increased from 1.46 (Mar 24) to 15.44, marking an increase of 13.98.
• For Enterprise Value (Cr.), as of Mar 25, the value is 823.78. It has increased from 458.80 (Mar 24) to 823.78, marking an increase of 364.98.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.09. This value exceeds the healthy maximum of 3. It has increased from 5.33 (Mar 24) to 6.09, marking an increase of 0.76.
• For EV / EBITDA (X), as of Mar 25, the value is 18.79. This value exceeds the healthy maximum of 15. It has decreased from 29.53 (Mar 24) to 18.79, marking a decrease of 10.74.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.11. This value exceeds the healthy maximum of 3. It has increased from 5.06 (Mar 24) to 6.11, marking an increase of 1.05.
• For Price / BV (X), as of Mar 25, the value is 8.34. This value exceeds the healthy maximum of 3. It has increased from 6.24 (Mar 24) to 8.34, marking an increase of 2.10.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.11. This value exceeds the healthy maximum of 3. It has increased from 5.06 (Mar 24) to 6.11, marking an increase of 1.05.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.03, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness